Charles river and captain t cell announce plasmid dna and viral vector manufacturing alliance for gene-modified cell therapy

Wilmington, mass.--(business wire)--charles river laboratories international, inc. (nyse: crl) and captain t cell, a spinoff from the renowned max delbrÜck center berlin, germany, today announced a plasmid dna and retrovirus vector production program agreement. as part of charles river's cell and gene therapy (cgt) accelerator program (cap), captain t cell will have access to established plasmid and viral vector contract development and manufacturing organization (cdmo) capabilities and advisor.
DNA Ratings Summary
DNA Quant Ranking